WST · 10-Q · 2026Q3 · Full report

Interest Rate Environment

WEST PHARMACEUTICAL SERVICES INC · 2026-10-29 · Importance 45 · Surprise 64

For the nine months ended September 30, 2026, net interest expense increased $7.6 million year over year, from $0.7 million to $8.3 million. The filing attributes the increase primarily to lower capitalized interest, partially offset by declining interest rates on the Company’s Term Loan. For the three months ended September 30, 2026, net interest expense increased $3.6 million, to $3.8 million, with the same factors identified.

Key facts

• WEST PHARMACEUTICAL SERVICES INC’s net interest expense increased $3.6 million and $7.6 million for the three and nine months ended September 30, 2026, respectively, primarily because of lower capitalized interest, partly offset by lower Term Loan interest rates. source